A 58-year-old man with rheumatoid arthritis develops a maculopapular rash 2 weeks after starting methotrexate. The rash is not dose-dependent and occurs despite using the drug at standard therapeutic doses. Which classification of adverse drug reaction does this represent, and what is the best discriminating feature from Type A reactions?